Valuation dashboard for Apollomics, Inc. (APLM) with P/E N/A, P/B -2.92, EV/EBITDA -6.10 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements.
Analysis Summary
Apollomics, Inc. reported revenue of $8.5M in the most recent fiscal year, growing at a 5-year CAGR of 35.8%.
Trailing-twelve-month margins: gross margin 100.0%, operating margin -111.4%, net margin -128.7%.
At the current price of $22.11, APLM has negative trailing earnings (P/E not meaningful) and an ROE of 288.40%. Market capitalisation stands at $49M.
Balance sheet quality for APLM: current ratio of 1.0. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | -2.92 |
| EV / EBITDA | -6.10 |
| Dividend Yield | 0.00% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| APLM | Apollomics, Inc. | $49M | 288.4% | ||
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.3B | 29.68 | 6.45 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $22.11 |
| Market Cap | $49M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | 288.40% |
| Return on Invested Capital | -1586.77% |
| Return on Assets | -162.93% |
| Gross Margin | 100.00% |
| Operating Margin | -111.45% |
| Net Margin | -128.69% |
Related companies: ADAP · ANL · ATHA · BLRX · GOVX · ICU · LNAI
Explore sector: Healthcare · Biotechnology
More sections of APLM: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks